Calcium alginate-chitosan sustained-release microsphere carrying growth hormone and application thereof
A technology of growth hormone and calcium alginate, which is applied to the preparation of microspheres, microcapsule preparations, medical preparations of non-active ingredients, etc., can solve the problems that growth hormone cannot be used for embedding, slow release and protection, so as to enhance the human body Effects on immune function, blood lipid reduction, and narrow particle size distribution
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0022] The somatotropin-loaded calcium alginate chitosan slow-release microspheres of the present embodiment, its main component is somatotropin, calcium alginate, chitosan, adopts following steps to prepare:
[0023] First, accurately measure 10IU / mL growth hormone injection and 15mg / ml sodium alginate solution, mix them uniformly at a volume ratio of 1:4, and put them into a syringe; The aperture is 450um, the negative electrode is connected to the metal conductive ring placed in the gel bath solution, and a pulse electrostatic field is formed between the orifice and the gel bath. The pulse electric field device indicates a voltage of 380V, a pulse frequency of 120Hz, and a pulse width of 2ms; the syringe will The liquid is pushed out, the flow rate of the raw material liquid is 8mL / h, and the inherent viscous force and surface tension of the sodium alginate solution are overcome under the action of the electric field force, so that the mixed solution drops into 20mg / ml CaCl ...
Embodiment 2
[0025] The somatotropin-loaded calcium alginate chitosan slow-release microspheres of the present embodiment, its main component is somatotropin, calcium alginate, chitosan, adopts following steps to prepare:
[0026]First, accurately measure 10IU / mL growth hormone injection and 20mg / ml sodium alginate solution, mix them uniformly at a volume ratio of 1:4, and put them into a syringe; The aperture is 600um, the negative electrode is connected to the metal conductive ring placed in the gel bath solution, and a pulse electrostatic field is formed between the orifice and the gel bath. The pulse electric field device indicates a voltage of 380V, a pulse frequency of 120Hz, and a pulse width of 2ms; the syringe will The liquid is pushed out, the flow rate of the raw material liquid is 25mL / h, and the inherent viscous force and surface tension of the sodium alginate solution are overcome under the action of the electric field force, so that the mixed solution drops into 30mg / ml CaCl ...
Embodiment 3
[0028] The somatotropin-loaded calcium alginate chitosan slow-release microspheres of the present embodiment, its main component is somatotropin, calcium alginate, chitosan, adopts following steps to prepare:
[0029] First, accurately measure 10IU / mL growth hormone injection and 5mg / ml sodium alginate solution, mix them uniformly at a volume ratio of 1:4, and put them into a syringe; The aperture is 500um, the negative electrode is connected to the metal conductive ring placed in the gel bath solution, and a pulse electrostatic field is formed between the aperture and the gel bath. The pulse electric field device indicates a voltage of 380V, a pulse frequency of 120Hz, and a pulse width of 2ms; the syringe will The liquid is pushed out, the flow rate of the raw material liquid is 50mL / h, and the inherent viscous force and surface tension of the sodium alginate solution are overcome under the action of the electric field force, so that the mixed solution drops into 5mg / ml CaCl ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap